Informed Consent

(Image: iStock/thomas-bethge)

Reports revisited: What we learned this year

By Melissa Fassbender

Outsourcing models examined, market shifts scrutinized, and trial tribulations analyzed – take a look back at some of the top reports published in 2017.

(Image: iStock/Ivanko_Brnjakovic)

WIRB-Copernicus Group acquires eConsent tech

By Melissa Fassbender

WIRB-Copernicus Group (WCG) has acquired eConsent technology to help clinical trial volunteers – and their families – make more informed decisions, says CEO.

US plans to require trial consent publication

TRIAL TRANSPARENCY

US plans to require trial consent publication

By Fiona BARRY

The US government may require companies running clinical trials to post their informed consent forms publicly, under rules proposed by the Department of Health and Human Services (HHS).

Harvard professors question aspects of 21st Century Cures Act

Harvard professors question aspects of 21st Century Cures Act

By Zachary Brennan

The 21st Century Cures Act may actually offer the FDA too much discretion to approve drugs without conventional clinical trials, and in some cases “on the basis of less rigorous data,” two medicine professors from Harvard write in an editorial in the...

Icon funds new research on informed consent at Carnegie Mellon

Icon funds new research on informed consent at Carnegie Mellon

By Zachary Brennan

Dublin-based CRO Icon is sponsoring a series of research projects at Carnegie Mellon University as part of a long-term partnership to find new ways to improve the comprehension and retention of informed consent documents by clinical trial participants. 

A second wave of comments is released.

ACRO, Dana Farber seek more info on FDA informed consent draft guideline

By Zachary Brennan

More commentary on the US FDA’s informed consent draft guidance is trickling out, this time with ACRO (Association of Clinical Research Organizations) and the Dana Farber Cancer Institute offering their take on what should be included in the final guidance.

Concerns raised over FDA’s informed consent draft guidance

Concerns raised over FDA’s informed consent draft guidance

By Zachary Brennan

The US FDA was flooded with comments on its draft guidance seeking to amend the informed consent process – with some saying the guidance will further confuse patients while others took issue with what the revisions didn’t include.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All